Treatment of Acute Respiratory Failure in the Course of COVID-19. Practical Hints from the Expert Panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society
Advances in Respiratory Medicine · 18.07.2020 · 88 (3) · 245-266
DOI: 10.5603/arm.2020.0109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 18.07.2020. Verfasst von Malgorzata Czajkowska-Malinowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Diseases and Respiratory Failure, Centre of Sleep Medicine and Respiratory Care, Kujawy-Pomerania Pulmonology Centre, Bydgoszcz, P…. Hauptthemen laut MEDLINE: Betacoronavirus, Practice Guidelines as Topic. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
In 2019, a pandemic began due to infection with a novel coronavirus, SARS-CoV-2. In many cases, this coronavirus leads to the development of the COVID-19 disease. Lung damage in the course of this disease often leads to acute hypoxic respiratory failure and may eventually lead to acute respiratory distress syndrome (ARDS). Respiratory failure as a result of COVID-19 can develop very quickly and a small percent of those infected will die because of it. There is currently no treatment for COVID-19, therefore the key therapeutic intervention centers around the symptomatic treatment of respiratory failure. The main therapeutic goal is to main-tain gas exchange, mainly oxygenation, at an appropriate level and prevent the intensification of changes in the lung parenchyma. Depending on the severity of hypoxemia different techniques can be used to improve oxygenation. Medical staff dealing with COVID-19 patients should be familiar with both, methods used to treat respiratory failure and the epidemiological risks arising from their use. In some patients, conventional (passive) oxygen therapy alone is sufficient. In patients with worsening respiratory failure high flow nasal oxygen therapy (HFNOT) may be effective. The continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) methods can be used to a limited extent. With further disease progression, invasive ventilation must be used and in special situations, extracorporeal membrane oxygenation (ECMO) can also be administered. The authors of this article set themselves the goal of presenting the most current knowledge about the epidemiology and patho-physiology of respiratory failure in COVID-19, as well as the methods of its treatment. Given the dynamics of the developing pandemic, this is not an easy task as new scientific data is presented almost every day. However, we believe the knowledge contained in this study will help doctors care for patients with COVID-19. The main target audience of this study is not so much pneumonologists or intensivists who have extensive experience in the application of the techniques discussed here, but rather doctors of other specializations who must master new skills in order to help patients during the time of a pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lung Diseases and Respiratory Failure, Centre of Sleep Medicine and Respiratory Care, Kujawy-Pomerania Pulmonology Centre, Bydgoszcz, Poland. m.cz.malinowska@interia.pl.
- Jagiellonian University Medical College, Faculty of Medicine, Second Department of Medicine, Department of Pulmonology, Kraków, Poland.
- Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
- Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland.
- Department of Pneumonology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
- Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Military Medical Institute, Warsaw, Poland.
Zitieren
APA
Czajkowska-Malinowska, M., Kania, A., Kuca, P. J., Nasiłowski, J., Skoczyński, S., Sokołowski, R., & Śliwiński, P. S. (2020). Treatment of Acute Respiratory Failure in the Course of COVID-19. Practical Hints from the Expert Panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society. Advances in Respiratory Medicine, 88(3), 245-266. https://doi.org/10.5603/arm.2020.0109
Vancouver
Czajkowska-Malinowska M, Kania A, Kuca PJ, Nasiłowski J, Skoczyński S, Sokołowski R, et al. Treatment of Acute Respiratory Failure in the Course of COVID-19. Practical Hints from the Expert Panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society. Advances in Respiratory Medicine. 2020;88(3):245-266. doi:10.5603/arm.2020.0109
BibTeX
@article{CzajkowskaMalinowska2020,
author = {Czajkowska-Malinowska, Malgorzata and Kania, Aleksander and Kuca, Paweł Jan and Nasiłowski, Jacek and Skoczyński, Szymon and Sokołowski, Rafał and Śliwiński, Paweł Stanislaw},
title = {Treatment of Acute Respiratory Failure in the Course of COVID-19. Practical Hints from the Expert Panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society},
journal = {Advances in Respiratory Medicine},
year = {2020},
volume = {88},
number = {3},
pages = {245--266},
doi = {10.5603/arm.2020.0109}
}
EUVIMED